Sumitomo Life Insurance Co. Buys Shares of 4,697 Synopsys, Inc. $SNPS

Sumitomo Life Insurance Co. purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPS) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 4,697 shares of the semiconductor company’s stock, valued at approximately $2,095,000.

Several other institutional investors and hedge funds have also bought and sold shares of SNPS. BlackRock Inc. purchased a new position in shares of Synopsys during the 2nd quarter valued at $7,228,099,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in Synopsys during the second quarter worth about $747,400,000. Norges Bank purchased a new position in shares of Synopsys in the fourth quarter worth about $730,197,000. Bank of New York Mellon Corp purchased a new stake in shares of Synopsys during the 2nd quarter valued at approximately $692,074,000. Finally, State Street Corp boosted its holdings in Synopsys by 20.6% in the 3rd quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company’s stock worth $4,322,273,000 after buying an additional 1,493,912 shares during the period. 85.47% of the stock is owned by institutional investors.

Synopsys Trading Down 0.0%

NASDAQ SNPS opened at $397.87 on Friday. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The stock’s 50-day simple moving average is $419.73 and its two-hundred day simple moving average is $440.22. Synopsys, Inc. has a twelve month low of $366.00 and a twelve month high of $615.79. The company has a market capitalization of $76.18 billion, a price-to-earnings ratio of 92.10, a PEG ratio of 2.34 and a beta of 1.23.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating the consensus estimate of $3.15 by $0.20. The firm had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The company’s revenue was up 41.9% on a year-over-year basis. During the same period in the prior year, the company earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Research analysts forecast that Synopsys, Inc. will post 10.65 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. Weiss Ratings reiterated a “hold (c-)” rating on shares of Synopsys in a research report on Monday, June 8th. Benchmark reaffirmed a “buy” rating on shares of Synopsys in a report on Wednesday. Berenberg Bank set a $633.00 price target on Synopsys in a research report on Wednesday, May 27th. Rosenblatt Securities raised their price objective on shares of Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a research report on Tuesday, May 26th. Finally, Citigroup boosted their price objective on shares of Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $563.59.

Insiders Place Their Bets

In related news, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by corporate insiders.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.